Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Labcorp Holdings (LH), a healthcare diagnostics and drug development company, is identified as a strong value prospect despite its Zacks #3 (Hold) rank, driven by an A-rated VGM Score and B-rated Value Style Score, along with an attractive 16.94 forward P/E. Eight analysts have recently raised their 2025 earnings estimates, increasing the consensus to $16.30 per share, complemented by a historical average earnings surprise of +2.5%, indicating potential upside for investors.

Analysis

Labcorp Holdings (LH), a healthcare diagnostics and drug development company, presents a compelling value case despite its neutral Zacks #3 (Hold) rank. The stock's attractiveness is underpinned by strong quantitative style scores, including a top-tier VGM Score of 'A' and a Value Style Score of 'B', supported by a forward P/E ratio of 16.94. Critically, forward-looking sentiment is strengthening, evidenced by eight analysts revising their fiscal 2025 earnings estimates upward in the last 60 days. This collective revision has increased the Zacks Consensus Estimate for 2025 by $0.25 to $16.30 per share. This positive outlook is further reinforced by the company's historical performance, which includes an average earnings surprise of +2.5%, indicating a consistent ability to exceed expectations. While the formal 'Hold' rank suggests a neutral near-term outlook, the underlying fundamental metrics and positive analyst revisions signal potential for upside that value-focused investors may find attractive.

Key Decisions for Investors

• Value-oriented investors should consider Labcorp (LH) for their watchlists, given its favorable forward P/E of 16.94, B-rated Value Score, and positive earnings estimate momentum.
• Investors should weigh the positive fundamental signals, such as the upward revisions to fiscal 2025 earnings, against the neutral Zacks #3 (Hold) rank, which may imply limited price momentum over the next 30 days.
• It is prudent to monitor future earnings revisions and any subsequent changes to the Zacks Rank, as an upgrade from 'Hold' to 'Buy' could act as a significant bullish catalyst confirming the underlying positive trend.